MedPath

Effects of Continuous ESP Catheters on Recovery, Pain and Opioid Consumption After Multilevel Spine Surgery

Not Applicable
Terminated
Conditions
Spine Surgery
Post Operative Pain
Registration Number
NCT05494125
Lead Sponsor
Hospital for Special Surgery, New York
Brief Summary

Single-shot erector spinae plane (ESP) blocks (ESPB) are emerging as an intervention to improve pain and minimize opioid consumption after lumbar spine surgery. Although promising, there is minimal evidence to support routine use, and widespread clinical adoption may be limited to centers with advanced regional anesthesia resources and expertise. Continuous ESP catheter techniques may solve these problems but are associated with challenges of their own. This trial will investigate the role of adding surgeon-placed, continuous ESP catheters to single-shot ESPBs for patients undergoing multilevel spine surgery. It will assess whether adding ESP catheters with ropivacaine infusion for 48 hours after surgery offers opioid-minimizing analgesia and improves patient quality of recovery, compared to ESP catheters with saline/placebo infusion for 48 hours.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Age 18-80
  • Presenting for elective multilevel (>2 spinal levels) spinal fusion
  • Lumbar, thoracic, and thoracolumbar procedures included
  • Posterior surgical approach
  • Willing and able to follow the study protocol
  • Able to provide informed consent
Exclusion Criteria
  • Opioid tolerance (more than 60 morphine milliequivalents daily for more than 3 months)
  • Daily gabapentin/pregabalin use for longer than 3 months
  • Prior spine surgery at the index level
  • Allergy or contraindication (including renal, liver disease) to included study medications
  • Patient refusal

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of patients who require escalation to (ie, a new prescription for) an opioid-iv-patient controlled analgesia (iv-PCA)First 72 hours after surgery
Secondary Outcome Measures
NameTimeMethod
Numeric rating scale (NRS) pain scores: every 8 hoursBetween PACU and 72 hours post surgery

Scale of 0-10, 0 being no pain, 10 being the worst pain possible

Duration of use and dose of opioid-iv-pca (if required)First 72 hours after surgery

Measured in morphine equivalents daily

Post-operative opioid consumptionFrom PACU arrival to 72 hours post surgery

Measured in morphine equivalents daily

Duration of ESP catheter(s) use and reasons (if any) for catheter failure or dislodgementFirst 48 hours post surgery

Measured in days after placement

Opioid-related side effects (nausea, vomiting, anti-emetic medication administration, constipation, sedation, administration of naloxone)First 48 hours post surgery

If the patient ever had any of the events

Quality of Recovery 15 (QoR15) scoresPre-operative, holding area/day of surgery, 24 hours, 48 hours, 14 days and 42 days post surgery

The Quality of Recovery 15 (QoR15) is a 15-item questionnaire which assesses five domains of patient-reported health status: pain, physical comfort, physical independence, psychological support and emotional state. It has a minimum score of 0 (very poor recovery) and a maximum score of 150 (excellent recovery).

Total dose of ropivacaine deliveredFirst 48 hours post surgery

Measured in mg/kg/hr

Length of hospital stayFrom PACU arrival to hospital discharge, up to 2 weeks

Measured in days after surgery

Patient satisfaction scale with pain management and ESP cathetersFirst 72 hours, 14 days, and 42 days post surgery

Patient satisfaction will be assessed using a 0 to 10 scale (0 being not satisfied to 10 being totally satisfied)

Incidence of ongoing pain and opioid consumption, measured at 3 and 6 months post-surgery3 and 6 month post surgery

Measured with a 7-item questionnaire to assess chronic pain and opioid use

Trial Locations

Locations (1)

Hospital for Special Surgery

🇺🇸

New York, New York, United States

Hospital for Special Surgery
🇺🇸New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath